Trial Profile
Safety and efficacy of anbainuo a bio-similar etanercept in patients with moderate to severe rheumatoid arthritis inadequately responding to methotrexate
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 31 Oct 2017 New trial record